Literature DB >> 2498098

Isolation of Francisella tularensis biovar palaearctica from human blood.

A Tärnvik1, C Henning, E Falsen, G Sandström.   

Abstract

Francisella tularensis septicemia has previously been reported in the USA, where Francisella tularensis biovar tularensis (type A) occurs endemically. The present report describes two cases of septicemia caused by the Euro-Asian Francisella tularensis biovar palaearctica (type B). The patients lived in an endemic region of Sweden and presented with high fever and pneumonia. Both patients recovered. The ability of Francisella tularensis biovar palaearctica to cause bacteremia has consequences for laboratory safety.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498098     DOI: 10.1007/bf01963900

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics.

Authors:  E L OVERHOLT; W D TIGERTT; P J KADULL; M K WARD; N D CHARKES; R M RENE; T E SALZMAN; M STEPHENS
Journal:  Am J Med       Date:  1961-05       Impact factor: 4.965

2.  Laboratory-acquired tularemia in vaccinated individuals: a report of 62 cases.

Authors:  T E VAN METRE; P J KADULL
Journal:  Ann Intern Med       Date:  1959-03       Impact factor: 25.391

3.  LIVE TULAREMIA VACCINE I. : Host-Parasite Relationship in Monkeys Vaccinated Intracutaneously or Aerogenically.

Authors:  H T Eigelsbach; J J Tulis; M H McGavran; J D White
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

4.  Airborne tularemia in Sweden.

Authors:  S Dahlstrand; O Ringertz; B Zetterberg
Journal:  Scand J Infect Dis       Date:  1971

5.  A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes.

Authors:  G Sandström; S Löfgren; A Tärnvik
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

Review 6.  Tularemia: a 30-year experience with 88 cases.

Authors:  M E Evans; D W Gregory; W Schaffner; Z A McGee
Journal:  Medicine (Baltimore)       Date:  1985-07       Impact factor: 1.889

7.  Isolation of Francisella tularensis from blood.

Authors:  J M Provenza; S A Klotz; R L Penn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Virulence and citrulline ureidase activity of Pasteurella tularensis.

Authors:  N J MARCHETTE; P S NICHOLES
Journal:  J Bacteriol       Date:  1961-07       Impact factor: 3.490

9.  Pathogenesis of tularemia in monkeys aerogenically exposed to Francisella tularensis 425.

Authors:  R L Schricker; H T Eigelsbach; J Q Mitten; W C Hall
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

10.  Cellular fatty acid composition of Francisella tularensis.

Authors:  E Jantzen; B P Berdal; T Omland
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

  10 in total
  8 in total

1.  Treatment of tularemia with ciprofloxacin.

Authors:  O Scheel; R Reiersen; T Hoel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Francisella tularensis bacteremia.

Authors:  X Haristoy; A Lozniewski; C Tram; D Simeon; L Bevanger; C Lion
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

3.  Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.

Authors:  Michael A Apicella; Deborah M B Post; Andrew C Fowler; Bradley D Jones; Jed A Rasmussen; Jason R Hunt; Sayaka Imagawa; Biswa Choudhury; Thomas J Inzana; Tamara M Maier; Dara W Frank; Thomas C Zahrt; Kathryn Chaloner; Michael P Jennings; Molly K McLendon; Bradford W Gibson
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

4.  Water- and airborne Francisella tularensis biovar palaearctica isolated from human blood.

Authors:  T Hoel; O Scheel; S H Nordahl; T Sandvik
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

Review 5.  Tularemia.

Authors:  Jill Ellis; Petra C F Oyston; Michael Green; Richard W Titball
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

6.  Francisella tularensis peritonitis in stomach cancer patient.

Authors:  Xiang Y Han; Linus X Ho; Amar Safdar
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

7.  The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.

Authors:  Tina Guina; Lynda L Lanning; Kristian S Omland; Mark S Williams; Larry A Wolfraim; Stephen P Heyse; Christopher R Houchens; Patrick Sanz; Judith A Hewitt
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

8.  Severe infections due to Francisella tularensis ssp. holarctica in solid organ transplant recipient: report of two cases and review of literature.

Authors:  Olivier Bahuaud; Cécile Le Brun; Thomas Chalopin; Marion Lacasse; Julien Le Marec; Clémence Pantaleon; Charlotte Nicolas; Louise Barbier; Louis Bernard; Adrien Lemaignen
Journal:  BMC Infect Dis       Date:  2019-03-08       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.